SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,107.42 |
| Enterprise Value ($M) | 1,137.64 |
| Book Value ($M) | -246.17 |
| Book Value / Share | -0.91 |
| Price / Book | -4.50 |
| NCAV ($M) | -347.97 |
| NCAV / Share | -1.29 |
| Price / NCAV | -3.18 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.09 |
| Return on Assets (ROA) | -0.04 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.31 |
| Current Ratio | 3.59 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 373.39 |
| Assets | 475.20 |
| Liabilities | 721.37 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 198.96 |
| Operating Income | 10.59 |
| Net Income | -11.94 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 34.09 |
| Cash from Investing | -1.99 |
| Cash from Financing | 136.61 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.66 | 11.60 | |
| 13G/A | BlackRock Inc. | 8.30 | 6.13 | |
| 13G/A | State Street Corp | 4.80 | -25.02 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 175,871 | 826,473 | 21.28 | |
| 260,334 | 1,845,915 | 14.10 | |
| 156,293 | 415,117 | 37.65 | |
| 169,712 | 514,389 | 32.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MACK – Merrimack Pharmaceuticals, Inc. | MDWD – MediWound Ltd. |
| MIRM – Mirum Pharmaceuticals, Inc. | MNOV – MediciNova, Inc. |
| MORF – Morphic Holding, Inc. |